Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Change in Accured Expenses (2010 - 2026)

Omnicell's (OMCL) quarterly Change in Accured Expenses came in at $14.4 million in Q2 2026, up 2301.84% year-over-year from $598625.0 in Q2 2025, and up 233.56% quarter-over-quarter from -$10.8 million in Q1 2026.

Analysis

Omnicell (OMCL) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Change in Accured Expenses for 17 consecutive years, with $14.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 2301.84% year-over-year to $14.4 million in Q2 2026; TTM through Jun 2026 was -$461000.0, a 95.48% increase from a year earlier, with the FY2025 full-year figure at -$19.0 million, down 235.97% from the prior year.
  • Change in Accured Expenses was $14.4 million for Q2 2026 at Omnicell, up from -$10.8 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $44.6 million in Q4 2022 and troughed at -$25.2 million in Q1 2023.
  • A 5-year average of -$345111.1 and a median of -$1.5 million in 2024 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses sank 268.1% in 2022 and soared 2301.84% in 2026, its largest moves.
  • Over 5 years, Change in Accured Expenses stood at $44.6 million in 2022, then sank by 82.22% to $7.9 million in 2023, then slipped by 11.98% to $7.0 million in 2024, then plunged by 184.51% to -$5.9 million in 2025, then jumped by 343.78% to $14.4 million in 2026.
  • The last three Change in Accured Expenses figures came in at $14.4 million (Q2 2026), -$10.8 million (Q1 2026), and -$5.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 55.00 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -531.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 298.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 234.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 123.70 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 112.90 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 50.56 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 14.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.38 Mn
Mar 31, 2026 -10.77 Mn
Dec 31, 2025 -5.90 Mn
Sep 30, 2025 1.82 Mn
Jun 30, 2025 -653,000.00
Mar 31, 2025 -14.23 Mn
Dec 31, 2024 6.98 Mn
Sep 30, 2024 -2.28 Mn
Jun 30, 2024 19.53 Mn
Mar 31, 2024 -10.28 Mn
Dec 31, 2023 7.93 Mn
Sep 30, 2023 -8.41 Mn
Jun 30, 2023 4.19 Mn
Mar 31, 2023 -25.17 Mn
Dec 31, 2022 44.59 Mn
Sep 30, 2022 -16.82 Mn
Jun 30, 2022 12.74 Mn
Mar 31, 2022 -23.86 Mn
Dec 31, 2021 14.71 Mn
Sep 30, 2021 10.01 Mn